Blockchain Technology To Be Used In Supply Of Drugs In US
The US Food and Drug Administration (FDA) has proposed to develop a pilot project in the pharmaceutical industry that will help monitor the production and supply chain of medicines. The document is published on the website of the Administration.
The pilot project will be implemented in accordance with the Drug Supply Chain Security Act (DSCSA). It aims to attract medical companies that are interested in the development of innovative technologies. The applications from participants will be accepted until March 11.
This is the first step of the FDA in the future development of the supply chain on the blockchain, which will help monitor the quality of medicines and prevent the production of counterfeit goods. The project will be fully launched in 2023.
The FDA is investing in the study of new ways of tracking products that may be applicable to the supply of medicines, and one of these methods is blockchain technology, Scott Gottlieb, the head of the FDA, stated.
The initiative to implement the DSCSA appeared in 2013, back then it received the status of a law providing for the creation of an electronic system for identifying and tracking prescription drugs.
The Administration did not disclose the scope of the pilot project. It is not yet known which companies and institutions will become its participants, and what interest exists.
As previously reported, the Food and Drug Administration of the Chinese city of Chongqing plans to use blockchain technology in its work.